首页> 外国专利> Devices and methods for injectable vascular sclerofoams using a carrier matrix and uses thereof

Devices and methods for injectable vascular sclerofoams using a carrier matrix and uses thereof

机译:使用载体矩阵的可注射血管硬化剂的装置和方法及其用途

摘要

The invention relates in particular to an injectable sclerosant drug foam comprising: (i) a matrix; (ii) at least one fluid; (iii) at least one sclerosant drug; (iv) a medical gas or medical gas mixture acceptable for intravenous use, (v) wherein said matrix has physical properties, which are comparable to denatured blood, wherein the denatured blood is obtainable from a fresh human venous whole blood sample of 1 ml volume, which is heated in a cylindrical polyethylene container with 3 mm inner diameter and 3.4 mm outer diameter for about 0.5 min. to about 10 min. at a temperature of about between 70° C. and 100° C. and/or (vii) said level of denaturation is defined by the change of red-colored hemoglobin to brown as an indicator, wherein Fe2+ is reduced to Fe3+ in the hemoglobin complex to a degree of at least 80%, preferably 90% and even more preferably 95%.
机译:本发明尤其涉及一种可注射的硬化剂药物泡沫,其包含:(i)基质; (ii)至少一种流体; (iii)至少一种硬化药物; (iv)(IV)可接受的静脉内使用的医疗气体或医用气体混合物(V),其中所述基质具有与变性血液相当的物理性质,其中变性血液可从1ml体积的新鲜人静脉全血样品中获得 ,其在圆柱形聚乙烯容器中加热,其中3mm内径和3.4mm外径约0.5分钟。 大约10分钟。 / /或(VII)所以所述变性水平由红色血红蛋白作为指示剂的棕色变化,其中Fe2 +在血红蛋白中减少至Fe3 +。 复合物至至少80%,优选90%,甚至更优选为95%。

著录项

  • 公开/公告号US11229601B2

    专利类型

  • 公开/公告日2022-01-25

    原文格式PDF

  • 申请/专利权人 SWISS VX VENENTHERAPIE UND FORSCHUNG GMBH;

    申请/专利号US201916417963

  • 发明设计人 JOHANN CHRISTOF RAGG;

    申请日2019-05-21

  • 分类号A61K9/12;A61K9;A61K35/14;A61K31/045;A61K31/185;A61K31/45;A61K31/255;A61K31/08;

  • 国家 US

  • 入库时间 2022-08-24 23:31:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号